1. Home
  2. NTLA vs TBLA Comparison

NTLA vs TBLA Comparison

Compare NTLA & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • TBLA
  • Stock Information
  • Founded
  • NTLA 2014
  • TBLA 2007
  • Country
  • NTLA United States
  • TBLA United States
  • Employees
  • NTLA N/A
  • TBLA N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TBLA Computer Software: Programming Data Processing
  • Sector
  • NTLA Health Care
  • TBLA Technology
  • Exchange
  • NTLA Nasdaq
  • TBLA Nasdaq
  • Market Cap
  • NTLA 1.2B
  • TBLA 1.2B
  • IPO Year
  • NTLA 2016
  • TBLA N/A
  • Fundamental
  • Price
  • NTLA $13.60
  • TBLA $3.33
  • Analyst Decision
  • NTLA Buy
  • TBLA Strong Buy
  • Analyst Count
  • NTLA 19
  • TBLA 4
  • Target Price
  • NTLA $35.11
  • TBLA $4.50
  • AVG Volume (30 Days)
  • NTLA 4.7M
  • TBLA 1.1M
  • Earning Date
  • NTLA 08-07-2025
  • TBLA 08-06-2025
  • Dividend Yield
  • NTLA N/A
  • TBLA N/A
  • EPS Growth
  • NTLA N/A
  • TBLA N/A
  • EPS
  • NTLA N/A
  • TBLA 0.04
  • Revenue
  • NTLA $45,569,000.00
  • TBLA $1,779,705,000.00
  • Revenue This Year
  • NTLA N/A
  • TBLA $7.69
  • Revenue Next Year
  • NTLA N/A
  • TBLA $6.15
  • P/E Ratio
  • NTLA N/A
  • TBLA $83.70
  • Revenue Growth
  • NTLA N/A
  • TBLA 16.63
  • 52 Week Low
  • NTLA $5.90
  • TBLA $2.50
  • 52 Week High
  • NTLA $27.42
  • TBLA $4.30
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 65.69
  • TBLA 32.08
  • Support Level
  • NTLA $12.48
  • TBLA $3.49
  • Resistance Level
  • NTLA $14.61
  • TBLA $3.66
  • Average True Range (ATR)
  • NTLA 0.90
  • TBLA 0.09
  • MACD
  • NTLA 0.13
  • TBLA -0.04
  • Stochastic Oscillator
  • NTLA 76.33
  • TBLA 2.15

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.

Share on Social Networks: